systematic use of tumor markers ( beta 1 -hcg and alpha fetoprotein ) , and perhaps an assessment of vascular invasion in the primary , might be useful to identify those patients in the unfavorable group who might benefit from elective chemotherapy .
C0041365
tumor markers
C0002210
alpha